174 related articles for article (PubMed ID: 22997693)
1. Limitations in activities of people affected by leprosy after completing multidrug therapy: application of the SALSA scale.
Nardi SM; Paschoal VD; Zanetta DM
Lepr Rev; 2012 Jun; 83(2):172-83. PubMed ID: 22997693
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the profession/occupation of individuals affected by leprosy and the relationship with limitations in professional activities.
Nardi SM; Ikehara E; Pedro HS; Paschoal VD
Indian J Lepr; 2012; 84(1):1-8. PubMed ID: 23077777
[TBL] [Abstract][Full Text] [Related]
3. The development of a short questionnaire for screening of activity limitation and safety awareness (SALSA) in clients affected by leprosy or diabetes.
; Ebenso J; Fuzikawa P; Melchior H; Wexler R; Piefer A; Min CS; Rajkumar P; Anderson A; Benbow C; Lehman L; Nicholls P; Saunderson P; Velema JP
Disabil Rehabil; 2007 May; 29(9):689-700. PubMed ID: 17453991
[TBL] [Abstract][Full Text] [Related]
4. The concurrent validity of the Amharic version of Screening of Activity Limitation and Safety Awareness (SALSA) in persons affected by leprosy.
Wijk U; Brandsma JW; Dahlström O; Björk M
Lepr Rev; 2013 Mar; 84(1):13-22. PubMed ID: 23741879
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the Screening Activity Limitation and Safety Awareness (SALSA) scale to objective hand function assessments.
Melchior H; Velema J
Disabil Rehabil; 2011; 33(21-22):2044-52. PubMed ID: 21955054
[TBL] [Abstract][Full Text] [Related]
6. Impairments in multibacillary leprosy; a study from Brazil.
Pimentel MI; Nery JA; Borges E; Gonçalves RR; Sarno EN
Lepr Rev; 2004 Jun; 75(2):143-52. PubMed ID: 15282965
[TBL] [Abstract][Full Text] [Related]
7. Neuropathic pain in people treated for multibacillary leprosy more than ten years previously.
Saunderson P; Bizuneh E; Leekassa R
Lepr Rev; 2008 Sep; 79(3):270-6. PubMed ID: 19009976
[TBL] [Abstract][Full Text] [Related]
8. Gender differences in epidemiological factors associated with treatment completion status of leprosy patients in the most hyperendemic district of Nepal.
Kumar RB; Singhasivanon P; Sherchand JB; Mahaisavariya P; Kaewkungwal J; Peerapakorn S; Mahotarn K
Southeast Asian J Trop Med Public Health; 2004 Jun; 35(2):334-9. PubMed ID: 15691132
[TBL] [Abstract][Full Text] [Related]
9. WHO disability grade does not influence physical activity in Brazilian leprosy patients.
Do Prado GD; Prado RB; Marciano LH; Nardi SM; Cordeiro JA; Monteiro HL
Lepr Rev; 2011 Sep; 82(3):270-8. PubMed ID: 22125935
[TBL] [Abstract][Full Text] [Related]
10. [Leprosy-related disabilities after release from multidrug treatment: prevalence and spatial distribution].
Nardi SM; Paschoal Vdel A; Chiaravalloti-Neto F; Zanetta DM
Rev Saude Publica; 2012 Dec; 46(6):969-77. PubMed ID: 23358621
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and impact of neuropathic pain in leprosy patients in Nepal after completion of multidrug therapy.
Toh HS; Maharjan J; Thapa R; Neupane KD; Shah M; Baral S; Hagge DA; Napit IB; Lockwood DNJ
PLoS Negl Trop Dis; 2018 Jul; 12(7):e0006610. PubMed ID: 29965957
[TBL] [Abstract][Full Text] [Related]
12. Physical disability and social participation in patients affected by leprosy after discontinuation of multidrug therapy.
de Castro LE; da Cunha AJ; Fontana AP; de Castro Halfoun VL; Gomes MK
Lepr Rev; 2014 Sep; 85(3):208-17. PubMed ID: 25509722
[TBL] [Abstract][Full Text] [Related]
13. Ocular findings in leprosy patients in Nepal in the era of multidrug therapy.
Nepal BP; Shrestha UD
Am J Ophthalmol; 2004 May; 137(5):888-92. PubMed ID: 15126154
[TBL] [Abstract][Full Text] [Related]
14. Social participation of people affected by leprosy after discontinuation of multidrug therapy.
Nardi SM; Paschoal VD; Zanetta DM
Lepr Rev; 2011 Mar; 82(1):55-64. PubMed ID: 21644472
[TBL] [Abstract][Full Text] [Related]
15. Functional Activity Limitation and Quality of Life of Leprosy Cases in an Endemic Area in Northeastern Brazil.
Santos VS; Oliveira LS; Castro FD; Gois-Santos VT; Lemos LM; Ribeiro Mdo C; Cuevas LE; Gurgel RQ
PLoS Negl Trop Dis; 2015; 9(7):e0003900. PubMed ID: 26132166
[TBL] [Abstract][Full Text] [Related]
16. Establishing the reliability and construct validity of the Igbo version of Screening Activity Limitation and Safety Awareness scale in persons with Hansen disease.
Ibikunle PO; Oladipo SE; Chukwu JN; Odole AC; Okeke AI
Lepr Rev; 2015 Sep; 86(3):220-8. PubMed ID: 26665357
[TBL] [Abstract][Full Text] [Related]
17. Test-retest reliability of the Screening Activity Limitation and Safety Awareness (SALSA) scale in North-West Nigeria.
Ebenso J; Velema JP
Lepr Rev; 2009 Jun; 80(2):197-204. PubMed ID: 19743624
[TBL] [Abstract][Full Text] [Related]
18. Four-year follow-up results of a WHO-recommended multiple-drug regimen in paucibacillary leprosy patients in Malawi.
Boerrigter G; Pönnighaus JM; Fine PE; Wilson RJ
Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):255-61. PubMed ID: 2071983
[TBL] [Abstract][Full Text] [Related]
19. Effects of impairments on activities and participation in people affected by leprosy in The Netherlands.
Slim FJ; van Schie CH; Keukenkamp R; Faber WR; Nollet F
J Rehabil Med; 2010 Jun; 42(6):536-43. PubMed ID: 20549158
[TBL] [Abstract][Full Text] [Related]
20. Impacts of the diagnosis of leprosy and of visible impairments amongst people affected by leprosy in Cebu, the Philippines.
Boku N; Lockwood DN; Balagon MV; Pardillo FE; Maghanoy AA; Mallari IB; Cross H
Lepr Rev; 2010 Jun; 81(2):111-20. PubMed ID: 20825115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
